APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha1-Proteinase Inhibitor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alpha1-Proteinase Inhibitor Industry Growth and Trends Forecast to 2032

22 December 202599 pages

Choose your research edition.

Industry ResearchAlpha1-Proteinase Inhibitor Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha1-Proteinase Inhibitor Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Alpha1-Proteinase Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha1-Proteinase Inhibitor Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha1-Proteinase Inhibitor Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Alpha1-Proteinase Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alpha1-Proteinase Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alpha1-Proteinase Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha1-Proteinase Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alpha1-Proteinase Inhibitor include Baxter, Talecris Biotherapeutics, Kamada, Grifols, CSL Behring and Aventis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alpha1-Proteinase Inhibitor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alpha1-Proteinase Inhibitor market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alpha1-Proteinase Inhibitor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alpha1-Proteinase Inhibitor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alpha1-Proteinase Inhibitor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alpha1-Proteinase Inhibitor Market by Company

Baxter

Talecris Biotherapeutics

Kamada

Grifols

CSL Behring

Aventis

Alpha1-Proteinase Inhibitor Segment by Type

Powder

Liquid

Alpha1-Proteinase Inhibitor Segment by Application

Hospital

Clinic

Alpha1-Proteinase Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha1-Proteinase Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha1-Proteinase Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha1-Proteinase Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alpha1-Proteinase Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alpha1-Proteinase Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Table 2. Major Company of Liquid Table 3. Global Alpha1-Proteinase Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (k tons) Table 5. Global Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type (2021-2026) Table 6. Global Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 7. Global Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type (2021-2026) Table 8. Global Alpha1-Proteinase Inhibitor Price by Type (2021-2026) & (US$/ton) Table 9. Global Alpha1-Proteinase Inhibitor Sales by Type (2027-2032) & (k tons) Table 10. Global Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type (2027-2032) Table 11. Global Alpha1-Proteinase Inhibitor Sales by Type (2027-2032) & (US$ Million) Table 12. Global Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type (2027-2032) Table 13. Global Alpha1-Proteinase Inhibitor Price by Type (2027-2032) & (US$/ton) Table 14. North America Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (k tons) Table 15. North America Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (k tons) Table 17. Europe Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (k tons) Table 19. Asia-Pacific Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (k tons) Table 21. Latin America Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (k tons) Table 23. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 24. Alpha1-Proteinase Inhibitor Industry Trends Table 25. Alpha1-Proteinase Inhibitor Industry Drivers Table 26. Alpha1-Proteinase Inhibitor Industry Opportunities and Challenges Table 27. Alpha1-Proteinase Inhibitor Industry Restraints Table 28. Global Alpha1-Proteinase Inhibitor Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Alpha1-Proteinase Inhibitor Revenue Market Share by Company (2021-2026) Table 30. Global Alpha1-Proteinase Inhibitor Sales by Company (2021-2026) & (k tons) Table 31. Global Alpha1-Proteinase Inhibitor Sales Share by Company (2021-2026) Table 32. Global Alpha1-Proteinase Inhibitor Market Price by Company (2021-2026) & (US$/ton) Table 33. Global Alpha1-Proteinase Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Alpha1-Proteinase Inhibitor Major Company Production Sites and Headquarters Table 35. Global Alpha1-Proteinase Inhibitor Company, Product Type & Application Table 36. Global Alpha1-Proteinase Inhibitor Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Alpha1-Proteinase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Alpha1-Proteinase Inhibitor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Alpha1-Proteinase Inhibitor Sales by Region (2021-2026) & (k tons) Table 41. Global Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Region (2021-2026) Table 42. Global Alpha1-Proteinase Inhibitor Sales by Region (2021-2026) & (US$ Million) Table 43. Global Alpha1-Proteinase Inhibitor Sales Market Share in Value by Region (2021-2026) Table 44. Global Alpha1-Proteinase Inhibitor Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 45. Global Alpha1-Proteinase Inhibitor Sales by Region (2027-2032) & (k tons) Table 46. Global Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Region (2027-2032) Table 47. Global Alpha1-Proteinase Inhibitor Sales by Region (2027-2032) & (US$ Million) Table 48. Global Alpha1-Proteinase Inhibitor Sales Market Share in Value by Region (2027-2032) Table 49. Global Alpha1-Proteinase Inhibitor Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 50. Global Alpha1-Proteinase Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (k tons) Table 52. Global Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application (2021-2026) Table 53. Global Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 54. Global Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application (2021-2026) Table 55. Global Alpha1-Proteinase Inhibitor Price by Application (2021-2026) & (US$/ton) Table 56. Global Alpha1-Proteinase Inhibitor Sales by Application (2027-2032) & (k tons) Table 57. Global Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application (2027-2032) Table 58. Global Alpha1-Proteinase Inhibitor Sales by Application (2027-2032) & (US$ Million) Table 59. Global Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application (2027-2032) Table 60. Global Alpha1-Proteinase Inhibitor Price by Application (2027-2032) & (US$/ton) Table 61. North America Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (k tons) Table 62. North America Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (k tons) Table 64. Europe Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (k tons) Table 66. Asia-Pacific Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (k tons) Table 68. Latin America Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (k tons) Table 70. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 71. Baxter Company Information Table 72. Baxter Business Overview Table 73. Baxter Alpha1-Proteinase Inhibitor Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Baxter Alpha1-Proteinase Inhibitor Product Portfolio Table 75. Baxter Recent Development Table 76. Talecris Biotherapeutics Company Information Table 77. Talecris Biotherapeutics Business Overview Table 78. Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Product Portfolio Table 80. Talecris Biotherapeutics Recent Development Table 81. Kamada Company Information Table 82. Kamada Business Overview Table 83. Kamada Alpha1-Proteinase Inhibitor Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Kamada Alpha1-Proteinase Inhibitor Product Portfolio Table 85. Kamada Recent Development Table 86. Grifols Company Information Table 87. Grifols Business Overview Table 88. Grifols Alpha1-Proteinase Inhibitor Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Grifols Alpha1-Proteinase Inhibitor Product Portfolio Table 90. Grifols Recent Development Table 91. CSL Behring Company Information Table 92. CSL Behring Business Overview Table 93. CSL Behring Alpha1-Proteinase Inhibitor Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. CSL Behring Alpha1-Proteinase Inhibitor Product Portfolio Table 95. CSL Behring Recent Development Table 96. Aventis Company Information Table 97. Aventis Business Overview Table 98. Aventis Alpha1-Proteinase Inhibitor Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. Aventis Alpha1-Proteinase Inhibitor Product Portfolio Table 100. Aventis Recent Development Table 101. North America Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 102. North America Alpha1-Proteinase Inhibitor Sales by Country (2021-2026) & (k tons) Table 103. North America Alpha1-Proteinase Inhibitor Sales Market Share by Country (2021-2026) Table 104. North America Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032) & (k tons) Table 105. North America Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 106. North America Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Alpha1-Proteinase Inhibitor Market Share by Country (2021-2026) Table 109. North America Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Alpha1-Proteinase Inhibitor Market Share Forecast by Country (2027-2032) Table 111. Europe Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 112. Europe Alpha1-Proteinase Inhibitor Sales by Country (2021-2026) & (k tons) Table 113. Europe Alpha1-Proteinase Inhibitor Sales Market Share by Country (2021-2026) Table 114. Europe Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032) & (k tons) Table 115. Europe Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Alpha1-Proteinase Inhibitor Market Share by Country (2021-2026) Table 119. Europe Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Alpha1-Proteinase Inhibitor Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Alpha1-Proteinase Inhibitor Sales by Country (2021-2026) & (k tons) Table 123. Asia-Pacific Alpha1-Proteinase Inhibitor Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032) & (k tons) Table 125. Asia-Pacific Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Alpha1-Proteinase Inhibitor Market Share by Country (2021-2026) Table 129. Asia-Pacific Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Alpha1-Proteinase Inhibitor Market Share Forecast by Country (2027-2032) Table 131. Latin America Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 132. Latin America Alpha1-Proteinase Inhibitor Sales by Country (2021-2026) & (k tons) Table 133. Latin America Alpha1-Proteinase Inhibitor Sales Market Share by Country (2021-2026) Table 134. Latin America Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032) & (k tons) Table 135. Latin America Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Alpha1-Proteinase Inhibitor Market Share by Country (2021-2026) Table 139. Latin America Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Alpha1-Proteinase Inhibitor Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country (2021-2026) & (k tons) Table 143. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032) & (k tons) Table 145. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Alpha1-Proteinase Inhibitor Market Share by Country (2021-2026) Table 149. Middle East and Africa Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Alpha1-Proteinase Inhibitor Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Alpha1-Proteinase Inhibitor Distributors List Table 154. Alpha1-Proteinase Inhibitor Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Alpha1-Proteinase Inhibitor Image Figure 2. Global Alpha1-Proteinase Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha1-Proteinase Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global Alpha1-Proteinase Inhibitor Sales (2021-2032) & (k tons) Figure 5. Powder Image Figure 6. Global Powder Sales YoY Growth (2021-2032) & (k tons) Figure 7. Liquid Image Figure 8. Global Liquid Sales YoY Growth (2021-2032) & (k tons) Figure 9. Global Alpha1-Proteinase Inhibitor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Alpha1-Proteinase Inhibitor Market Share by Type 2025 VS 2032 Figure 11. North America Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type in 2025 Figure 12. North America Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type in 2025 Figure 13. Europe Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type in 2025 Figure 14. Europe Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type in 2025 Figure 17. Latin America Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Alpha1-Proteinase Inhibitor Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k tons) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k tons) Figure 27. Global Alpha1-Proteinase Inhibitor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Alpha1-Proteinase Inhibitor Market Share by Application 2025 VS 2032 Figure 29. North America Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application in 2025 Figure 30. North America Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application in 2025 Figure 31. Europe Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application in 2025 Figure 32. Europe Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application in 2025 Figure 35. Latin America Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Market Share in Value by Application in 2025 Figure 39. North America Alpha1-Proteinase Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 40. North America Alpha1-Proteinase Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Alpha1-Proteinase Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Alpha1-Proteinase Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Alpha1-Proteinase Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 44. Europe Alpha1-Proteinase Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Alpha1-Proteinase Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Alpha1-Proteinase Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Alpha1-Proteinase Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. Asia-Pacific Alpha1-Proteinase Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Alpha1-Proteinase Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Alpha1-Proteinase Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Alpha1-Proteinase Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Latin America Alpha1-Proteinase Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Alpha1-Proteinase Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Alpha1-Proteinase Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Middle East and Africa Alpha1-Proteinase Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Alpha1-Proteinase Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Alpha1-Proteinase Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Alpha1-Proteinase Inhibitor Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Alpha1-Proteinase Inhibitor Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Hospital
  • Clinic
Companies covered
  • Baxter
  • Talecris Biotherapeutics
  • Kamada
  • Grifols
  • CSL Behring
  • Aventis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alpha1-Proteinase Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alpha1-Proteinase Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alpha1-Proteinase Inhibitor Market by Type
  6. 1.3.1 Powder
  7. 1.3.2 Liquid
  8. 1.4 Global Alpha1-Proteinase Inhibitor Market Size by Type
  9. 1.4.1 Global Alpha1-Proteinase Inhibitor Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Alpha1-Proteinase Inhibitor Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Alpha1-Proteinase Inhibitor Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Alpha1-Proteinase Inhibitor Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Alpha1-Proteinase Inhibitor Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Alpha1-Proteinase Inhibitor Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Alpha1-Proteinase Inhibitor Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Alpha1-Proteinase Inhibitor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alpha1-Proteinase Inhibitor Industry Trends
  2. 2.2 Alpha1-Proteinase Inhibitor Industry Drivers
  3. 2.3 Alpha1-Proteinase Inhibitor Industry Opportunities and Challenges
  4. 2.4 Alpha1-Proteinase Inhibitor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alpha1-Proteinase Inhibitor Revenue (2021-2026)
  2. 3.2 Global Top Players by Alpha1-Proteinase Inhibitor Sales (2021-2026)
  3. 3.3 Global Top Players by Alpha1-Proteinase Inhibitor Price (2021-2026)
  4. 3.4 Global Alpha1-Proteinase Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alpha1-Proteinase Inhibitor Major Company Production Sites & Headquarters
  6. 3.6 Global Alpha1-Proteinase Inhibitor Company, Product Type & Application
  7. 3.7 Global Alpha1-Proteinase Inhibitor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alpha1-Proteinase Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alpha1-Proteinase Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alpha1-Proteinase Inhibitor Tier 1, Tier 2, and Tier 3
4 Alpha1-Proteinase Inhibitor Regional Status and Outlook
  1. 4.1 Global Alpha1-Proteinase Inhibitor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alpha1-Proteinase Inhibitor Historic Market Size by Region
  3. 4.2.1 Global Alpha1-Proteinase Inhibitor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alpha1-Proteinase Inhibitor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alpha1-Proteinase Inhibitor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alpha1-Proteinase Inhibitor Forecasted Market Size by Region
  7. 4.3.1 Global Alpha1-Proteinase Inhibitor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alpha1-Proteinase Inhibitor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alpha1-Proteinase Inhibitor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alpha1-Proteinase Inhibitor by Application
  1. 5.1 Alpha1-Proteinase Inhibitor Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Alpha1-Proteinase Inhibitor Market Size by Application
  5. 5.2.1 Global Alpha1-Proteinase Inhibitor Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Alpha1-Proteinase Inhibitor Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Alpha1-Proteinase Inhibitor Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Alpha1-Proteinase Inhibitor Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Alpha1-Proteinase Inhibitor Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Alpha1-Proteinase Inhibitor Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Alpha1-Proteinase Inhibitor Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Alpha1-Proteinase Inhibitor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Alpha1-Proteinase Inhibitor Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Talecris Biotherapeutics
  8. 6.2.1 Talecris Biotherapeutics Company Information
  9. 6.2.2 Talecris Biotherapeutics Business Overview
  10. 6.2.3 Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Product Portfolio
  12. 6.2.5 Talecris Biotherapeutics Recent Developments
  13. 6.3 Kamada
  14. 6.3.1 Kamada Company Information
  15. 6.3.2 Kamada Business Overview
  16. 6.3.3 Kamada Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kamada Alpha1-Proteinase Inhibitor Product Portfolio
  18. 6.3.5 Kamada Recent Developments
  19. 6.4 Grifols
  20. 6.4.1 Grifols Company Information
  21. 6.4.2 Grifols Business Overview
  22. 6.4.3 Grifols Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Grifols Alpha1-Proteinase Inhibitor Product Portfolio
  24. 6.4.5 Grifols Recent Developments
  25. 6.5 CSL Behring
  26. 6.5.1 CSL Behring Company Information
  27. 6.5.2 CSL Behring Business Overview
  28. 6.5.3 CSL Behring Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSL Behring Alpha1-Proteinase Inhibitor Product Portfolio
  30. 6.5.5 CSL Behring Recent Developments
  31. 6.6 Aventis
  32. 6.6.1 Aventis Company Information
  33. 6.6.2 Aventis Business Overview
  34. 6.6.3 Aventis Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aventis Alpha1-Proteinase Inhibitor Product Portfolio
  36. 6.6.5 Aventis Recent Developments
7 North America by Country
  1. 7.1 North America Alpha1-Proteinase Inhibitor Sales by Country
  2. 7.1.1 North America Alpha1-Proteinase Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alpha1-Proteinase Inhibitor Sales by Country (2021-2026)
  4. 7.1.3 North America Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alpha1-Proteinase Inhibitor Market Size by Country
  6. 7.2.1 North America Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026)
  8. 7.2.3 North America Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alpha1-Proteinase Inhibitor Sales by Country
  2. 8.1.1 Europe Alpha1-Proteinase Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alpha1-Proteinase Inhibitor Sales by Country (2021-2026)
  4. 8.1.3 Europe Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alpha1-Proteinase Inhibitor Market Size by Country
  6. 8.2.1 Europe Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alpha1-Proteinase Inhibitor Sales by Country
  2. 9.1.1 Asia-Pacific Alpha1-Proteinase Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alpha1-Proteinase Inhibitor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alpha1-Proteinase Inhibitor Market Size by Country
  6. 9.2.1 Asia-Pacific Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alpha1-Proteinase Inhibitor Sales by Country
  2. 10.1.1 South America Alpha1-Proteinase Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alpha1-Proteinase Inhibitor Sales by Country (2021-2026)
  4. 10.1.3 South America Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alpha1-Proteinase Inhibitor Market Size by Country
  6. 10.2.1 South America Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026)
  8. 10.2.3 South America Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country
  2. 11.1.1 Middle East and Africa Alpha1-Proteinase Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alpha1-Proteinase Inhibitor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alpha1-Proteinase Inhibitor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alpha1-Proteinase Inhibitor Market Size by Country
  6. 11.2.1 Middle East and Africa Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alpha1-Proteinase Inhibitor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alpha1-Proteinase Inhibitor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alpha1-Proteinase Inhibitor Value Chain Analysis
  2. 12.1.1 Alpha1-Proteinase Inhibitor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alpha1-Proteinase Inhibitor Production Mode & Process
  7. 12.2 Alpha1-Proteinase Inhibitor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alpha1-Proteinase Inhibitor Distributors
  10. 12.2.3 Alpha1-Proteinase Inhibitor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst